American Bio Medica Corporation
ABMC · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $264 | $1,604 | $4,623 | $2,277 |
| - Cash | $34 | $115 | $98 | $4 |
| + Debt | $2,240 | $1,581 | $1,878 | $1,569 |
| Enterprise Value | $2,470 | $3,070 | $6,403 | $3,842 |
| Revenue | $913 | $2,218 | $4,147 | $3,655 |
| % Growth | -58.8% | -46.5% | 13.5% | – |
| Gross Profit | -$193 | $548 | $1,238 | $1,184 |
| % Margin | -21.1% | 24.7% | 29.9% | 32.4% |
| EBITDA | -$1,163 | -$199 | -$540 | -$340 |
| % Margin | -127.4% | -9% | -13% | -9.3% |
| Net Income | -$1,410 | -$463 | -$796 | -$681 |
| % Margin | -154.4% | -20.9% | -19.2% | -18.6% |
| EPS Diluted | -0.029 | -0.011 | -0.022 | -0.021 |
| % Growth | -172.2% | 51.8% | -7.2% | – |
| Operating Cash Flow | -$768 | -$673 | -$483 | $58 |
| Capital Expenditures | $0 | $0 | -$4 | $0 |
| Free Cash Flow | -$768 | -$673 | -$487 | $58 |